Thursday 17 August 2017 The one stop source for free breaking news, expert analysis, and videos on AIM and LSE listed shares

Concepta - adds to product with Stress Test deal

By HotStockRockets | Saturday 11 February 2017

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Concepta (CPT) has announced a deal that will enhance its fertility product MyLotus with an added stress test. Being stressed out can be a real issue when a chap is trying to get his Mrs up the duff.

The company says that it has signed a technology transfer and licence agreement with Selective Antibodies Ltd, a UK based diagnostics company , for the development of a stress test. Concepta says that this is part of the Company's new product development for its proprietary myLotus home self-testing platform that helps women with unexplained infertility* to conceive. This is in line with the strategy set out at the time of the Company's admission to AIM In 2016.

Concepta will pay Selective Antibodies for the development of the test and for technology transfer, plus a royalty based on sales of products developed using the IP. Work on the product development will start on 1st March 2017

This will be used to expand Concepta's existing myLotus platform capabilities (which includes measurements of a woman's personal hCG and LH hormone levels), enabling users to also monitor stress through quantitative measurement of their levels of stress hormones of which cortisol is the key one. Stress is a common cause of several health conditions and is widely recognised as a key factor, which can significantly impact both male and female fertility factors.

It all sounds jolly helpful but is very much jam tomorrow. And thus we are told:

"Furthermore, we remain on track for the launch of myLotus into the Chinese market in H1 2017, having appointed an experienced country manager before Christmas and with regulatory approval and manufacturing agreements in place. We look forward to updating the market further on this progress and, with ISO13485 accreditation in place, we continue to prepare for the commercial launch of myLotus in the UK and Europe towards the end of the year."

The shares will fly when big material sales start to arrive. Frankly we had hoped for news on this earlier. A clear update on the timetable for revenues and, even better, hard delivery will see the shares motor. On that basis we are, at 16.5p -18p well up on our share tip and we HOLD for a re-rate within months.

We continue to see a share price of a lot closer to 30p than 20p before long.

This article first appeared on HotStockRockets - its always paying customers first. To catch our next share tip of the month out in three weeks and a bonus tip in less than two weeks, for just £5, go HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on CPT


Comments are turned off for this article.

Site by Everywhen